...

U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost

World Materials 21 October 2021 05:46 (UTC +04:00)
U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost

The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans can choose a different shot from their original inoculation as a booster, Trend reports citing Reuters.

That means all three vaccines authorized in the United States can also be given as boosters to some groups.

"The availability of these authorized boosters is important for continued protection against COVID-19 disease," acting FDA Commissioner Janet Woodcock said in a statement. She noted that data suggests vaccine effectiveness may wane over time in some fully vaccinated people.

The decision paves the way for millions in the United States to get the additional protection as the highly contagious Delta variant of the virus causes breakthrough infections among some who are fully vaccinated.

The agency previously authorized boosters of the Pfizer Inc (PFE.N) COVID-19 vaccine developed with German partner BioNTech SE at least six months after the first round of shots to increase protection for people aged 65 and older, those at risk of severe disease and those who are exposed to the virus through their work.

Last week, an advisory panel to the FDA voted to recommend a third round of shots of the Moderna vaccine for the same groups. Moderna's booster is half the strength of the shots administered for the company's initial series of inoculations.

The panel also recommended a second shot of the J&J vaccine for all recipients of the one-dose inoculation at least two months after receiving their first.

Tags:
Latest

Latest